Invasive Fungal Infection in Hematological Malignancies

Invasive fungal infections (IFIs) present a formidable challenge in managing patients with hematological malignancies, marked by rising incidence rates and high mortality. The immunosuppression inherent to these patients, exacerbated by aggressive treatments, elevates their vulnerability to IFIs, particularly from Candida and Aspergillus species. This chapter offers an exhaustive overview of IFIs within this demographic, delving into epidemiology, risk factors, diagnostic strategies, and treatment modalities. Highlighting the importance of antifungal prophylaxis and the need for a multifaceted diagnostic approach, it aims to arm healthcare professionals with the knowledge to improve patient outcomes through early detection and tailored treatment strategies. By synthesizing the latest research with clinical practices, this chapter serves as an essential resource for those in hematology and critical care, striving to navigate the complexities of IFIs in patients with hematological malignancies.